Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Dosing: Obese Patients

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

Obesity

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Volume-Staged Stereotactic Radiosurgery in Pediatric Patients With Large Brain Arteriovenous Malformations: An International, Multicenter Study.

Neurosurgery·2026

Same author

Efficacy and safety profile of volume-staged stereotactic radiosurgery for ruptured, large pediatric arteriovenous malformations: a multicenter cohort analysis.

Journal of neurosurgery. Pediatrics·2026

Same author

Subdural and epidural hematoma following lumbar puncture in patients on anticoagulants or antiplatelets: A retrospective propensity score-matched registry study.

Acta neurologica Belgica·2026

Same author

Microsurgical Treatment of Ethmoidal Dural Arteriovenous Fistula.

World neurosurgery·2026

Same author

The Impact of Preoperative Nicotine Use in the Development of Opioid Use Disorder Following Lumbar Disc Discectomy Procedures: A National Database Study.

Cureus·2025

Same author

Outcome Evaluation of Volume-Staged Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations.

Neurosurgery·2025

Search research articles

Related Experiment Video

Updated: Nov 17, 2025

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment

Published on: November 22, 2024

Obesity and Mechanical Thrombectomy.

David R Hallan¹

¹Neurosurgery, Penn State Health Milton S. Hershey Medical Center, Hershey, USA.

|February 19, 2021

Summary

This summary is machine-generated.

Obese patients undergoing mechanical thrombectomy for ischemic stroke show reduced mortality rates compared to non-obese patients. This finding suggests a potential survival advantage for obese individuals in this specific patient group.

Keywords:

bmi cerebrovascular hemorrhagic conversion mortality neurosurgery obesity outcomes stroke thrombectomy trinetx

More Related Videos

An Acupoint Catgut-embedding Therapy for Treating Obesity

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

Related Experiment Videos

Last Updated: Nov 17, 2025

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment

Published on: November 22, 2024

An Acupoint Catgut-embedding Therapy for Treating Obesity

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

Area of Science:

Neurology
Cardiovascular Medicine
Public Health

Background:

Obesity is linked to improved survival in various medical conditions, including dialysis and rheumatoid arthritis.
The impact of obesity on outcomes for ischemic stroke patients, particularly those undergoing mechanical thrombectomy, remains unclear.
Existing research on obesity and ischemic stroke mortality shows conflicting results.

Purpose of the Study:

To investigate the effect of obesity on the outcomes of mechanical thrombectomy in ischemic stroke patients.
To determine if obesity confers a mortality benefit in patients treated with mechanical thrombectomy for stroke.

Main Methods:

Utilized a global health research network to collect electronic medical record data.
Stratified ischemic stroke patients who underwent mechanical thrombectomy into obese and non-obese cohorts.
Employed propensity score matching to control for confounding variables.

Main Results:

Obese patients had significantly lower mortality rates after mechanical thrombectomy compared to non-obese patients (p = 0.0033, OR = 0.81).
No significant differences were observed in ventilator dependence, hemicraniectomy, or post-procedure intracerebral hemorrhage between the groups.
The study identified a statistically significant reduction in mortality for obese individuals.

Conclusions:

Obesity is associated with decreased mortality in patients undergoing mechanical thrombectomy for ischemic stroke.
Despite higher risks for ischemic stroke, obese patients may experience better survival post-thrombectomy.
Further research is warranted to understand the mechanisms behind this obesity paradox in stroke treatment.